<DOC>
	<DOCNO>NCT00189878</DOCNO>
	<brief_summary>The purpose study determine whether methotrexate produce significant improvement chronic idiopathic urticaria , compare placebo</brief_summary>
	<brief_title>A Study Use Methotrexate Treatment Chronic Idiopathic Urticaria</brief_title>
	<detailed_description>Chronic idiopathic urticaria think affect approximately 0.1 % population . It disable difficult treat . Antihistamines drug license treatment urticaria , however group severely affect patient chronic idiopathic urticaria fail respond . Previous trial show ciclosporin beneficial , small study support use intravenous immunoglobulin plasmapheresis . However , option expensive , since chronic idiopathic urticaria may persist year , prolong use may limited adverse effect . We previously publish report 2 patient respond methotrexate , wish properly evaluate efficacy methotrexate treatment CIU . In first part study patient give either placebo methotrexate 8 week second part study , non-responders offer open label methotrexate 8 week .</detailed_description>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>severe unremitting chronic idiopathic urticaria disease resistant treatment antihistamine age 18 year predominant physical urticaria urticarial vasculitis contraindication use methotrexate , eg . pregnancy / breast feeding , woman want conceive man want father child within 12 month entry , use drug interact , underlie medical condition use immunosuppressant within 4 week entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>chronic idiopathic urticaria</keyword>
	<keyword>methotrexate</keyword>
</DOC>